JUR-003 in Adult Patients With Metastatic Prostate Cancer

JUR-003 in Adult Patients With Metastatic Prostate Cancer
Conditions: Metastatic Castration Resistant Prostate Cancer; Oligometastatic Prostate Cancer (OMPC); Metastatic Hormone Sensitive Prostate Cancer

Interventions: Biological: JUR-003

Sponsors: Juri Biosciences, Inc.

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 18, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments